tradingkey.logo
tradingkey.logo
Search

Scilex Holding Co

SCLX
Add to Watchlist
8.024USD
+0.144+1.83%
Market hours ETQuotes delayed by 15 min
56.43MMarket Cap
LossP/E TTM

TradingKey Stock Score of Scilex Holding Co

Currency: USD Updated: 2026-07-01

Key Insights

Scilex Holding Co's fundamentals are relatively weak, and its growth potential is high.Its valuation is considered fairly valued, ranking 119 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 490.00.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Scilex Holding Co's Score

Industry at a Glance

Industry Ranking
119 / 157
Overall Ranking
435 / 4564
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Scilex Holding Co Highlights

StrengthsRisks
Scilex Holding Company is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company’s commercial products include ZTlidoO (lidocaine topical system) 1.8% for the relief of neuropathic pain associated with postherpetic neuralgia (PHN); ELYXYB, a ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults; and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. In addition, it focuses on product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXAO), an epidural injections formulation to treat lumbosacral radicular pain, or sciatica; SP-103 (lidocaine topical system) 5.4%, a ZTlido formulation, for the treatment of acute pain; and SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (SP-104) for fibromyalgia treatment.
Growing
The company is in a growing phase, with the latest annual income totaling USD 30.25M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 30.25M.
Overvalued
The company’s latest PE is -0.19, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 1.44M shares, increasing 21.79% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 41.07 shares of this stock.

Analyst Rating

Based on 1 analysts
Hold
Current Rating
490.000
Target Price
+3319.40%
Upside Space

FAQs

How does TradingKey generate the Stock Score of Scilex Holding Co?

The TradingKey Stock Score provides a comprehensive assessment of Scilex Holding Co based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Scilex Holding Co’s performance and outlook.

How do we generate the financial health score of Scilex Holding Co?

To generate the financial health score of Scilex Holding Co, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Scilex Holding Co's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Scilex Holding Co.

How do we generate the company valuation score of Scilex Holding Co?

To generate the company valuation score of Scilex Holding Co, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Scilex Holding Co’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Scilex Holding Co’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Scilex Holding Co.

How do we generate the earnings forecast score of Scilex Holding Co?

To calculate the earnings forecast score of Scilex Holding Co, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Scilex Holding Co’s future.

How do we generate the price momentum score of Scilex Holding Co?

When generating the price momentum score for Scilex Holding Co, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Scilex Holding Co’s prices. A higher score indicates a more stable short-term price trend for Scilex Holding Co.

How do we generate the institutional confidence score of Scilex Holding Co?

To generate the institutional confidence score of Scilex Holding Co, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Scilex Holding Co’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Scilex Holding Co.

How do we generate the risk management score of Scilex Holding Co?

To assess the risk management score of Scilex Holding Co, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Scilex Holding Co’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Scilex Holding Co.